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Background: Patients with chronic conditions like hypertension may experience many negative emotions which
increase their risk for the development of mental health disorders particularly anxiety and depression. For Ghanaian
patients with hypertension, the interaction between hypertension and symptoms of anxiety, depression and stress
remains largely unexplored. To fill this knowledge gap, the study sought to ascertain the prevalence and role of
these negative emotions on anti-hypertensive medication adherence while taking into account patients’ belief
systems.
Methods: The hospital-based cross-sectional study involving 400 hypertensive patients was conducted in two
tertiary hospitals in Ghana. Data were gathered on patient’s socio-demographic characteristics, anxiety, depression
and stress symptoms, spiritual beliefs, and medication adherence.
Results: Hypertensive patients experienced symptoms of anxiety (56%), stress (20%) and depression (4%). As a
coping mechanism, a significant relation was observed between spiritual beliefs and anxiety (x2 = 13.352, p = 0.010),
depression (x2 = 6.205, p = 0.045) and stress (x2 = 14.833, p = 0.001). Stress among patients increased their likelihood
of medication non-adherence [odds ratio (OR) = 2.42 (95% CI 1.06 – 5.5), p = 0.035].
Conclusion: The study has demonstrated the need for clinicians to pay attention to negative emotions and their
role in medication non-adherence. The recommendation is that attention should be directed toward the use of
spirituality as a possible mechanism by which negative emotions could be managed among hypertensive patients.
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As disease burdens shift from infectious to non-
communicable diseases, hypertension is a principal precur-
sor to cardiovascular diseases and a main cause of death
globally [1,2]. About 80% of these deaths were recorded in
low- and middle- income countries and projections indi-
cate that the highest non-communicable mortality rates
would be recorded in these countries by 2020 [3]. Hyper-
tension affects approximately 25% of urban and 20% of
rural Ghanaian populations [4] and 11% - 42% of Africans* Correspondence: iakretchy@yahoo.com
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unless otherwise stated.[2,5-7]. A global hypertension prevalence of 26% is pro-
jected to ascend to 29% by the year 2025 [8].
Like patients with other chronic medical conditions,
hypertensive patients experience many profound emo-
tions which increase their risk for the development of
mental health disorders particularly anxiety and depres-
sion [9,10]. Imperative to the management of hyperten-
sion is the need for patients to adhere to pharmacological
and non-pharmacological therapies and these negative
emotions may adversely influence their adherence behav-
iour [11].
Anxiety and lower adherence rates have been observed
for asthma, heart failure, haemodialysis and contraceptive
use [12-15], although Kim et al. [16] noticed greater ad-
herence among the majority of their patients with anxiety
disorder.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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[17] and although prevalent, it is mostly undiagnosed in pa-
tients with hypertension [18]. Some relationship has been
observed between depression and non-adherence to med-
ical therapy [19,20] and a high number of prescribed medi-
cations were listed as one of the contributing factors for the
development of depressive symptoms in hypertension [21].
However not all studies successfully showed a relationship
between depressive symptoms and adherence [14,22].
The stress of having a chronic medical condition may
potentially influence medication adherence behaviour;
yet, earlier studies on emotional determinants of adher-
ence have largely focused on depression and anxiety
[12,14]. In clinical settings, stress has repeatedly been used
as a euphemism for negative emotions, particularly to ad-
dress undesirable psychiatric diagnostic labelling [23].
Stress negatively influenced medication adherence behav-
iour in HIV/AIDS [24] and acute coronary syndrome [25].
Empirical evidence showed the importance of stress in the
onset and worsening of essential hypertension [26], yet
there is a dearth of information associating stress and
medication adherence in hypertension management.
Drawing a causal relationship between anxiety, depres-
sion and stress, in hypertension and medication adherence
may be difficult [19]; but on the other hand, overlooking
the association may further decrease attempts to manage
the burden of medication non-adherence. For Ghanaian
patients with hypertension, this interaction between hyper-
tension and symptoms of anxiety, depression and stress
remains largely unexplored and incompletely understood
in terms of its prevalence and effect on medication adher-
ence. To fill this knowledge gap, the study sought to ascer-
tain 1) whether hypertensive patients exhibited symptoms
of anxiety, depression and stress; 2) whether individuals
experiencing anxiety, depression and stress symptoms
were more likely to be non-adherent than patients without
these symptoms; and 3) whether patients’ belief systems
had a relationship with anxiety, depression and stress
symptoms.
Methods
Study design and setting
A hospital-based cross-sectional study design was used.
The study was carried out at the two major teaching
hospitals in Ghana; Korle-Bu Teaching Hospital (KBTH),
Accra and Komfo Anokye Teaching Hospital (KATH),
Kumasi. The description of the study site has previously
been reported [27].
Participants
Two hundred (200) hypertensive outpatients each were
recruited from KBTH and KATH. Eligibility to participate
in the study was based on the following: A diagnosis ofhypertension only or hypertension with other co-morbid
conditions, reporting prescription of at least one antihy-
pertensive medication for a minimum of two months
and an age of at least eighteen years. The sample did
not include pregnant women (because of the possibility
of gestational hypertension which may resolve after de-
livery), newly diagnosed patients as well as the physic-
ally and mentally incapacitated [27].Measures
After informed written consent, a standardized quantitative
assessment tool was used to collect data concurrently
from the hypertensive patients attending KBTH and
KATH between May and October, 2012. The informa-
tion gathered covered three areas: i) demographic char-
acteristics; ii) anxiety, depression and stress measures
using the Depression Anxiety Stress Scale (DASS) – 21
[28]; iii) medication adherence behaviour using the
Morisky Medication Adherence Scale [29]; and iv) the
Spiritual Perspective Scale [30]. Participants were asked
about their age, sex, place of residence, religious affili-
ation, marital status, educational level, and duration of
hypertensive diagnosis.
The DASS is a 21 item self-report inventory that mea-
sures the negative emotional states of depression, anxiety
and stress. Each of the three scales comprised seven items
with related content. The depression subscale assessed dys-
phoria, hopelessness, devaluation of life, self-depreciation,
and lack of interest/involvement, anhedonia, and inertia.
The anxiety subscale measured autonomic arousal, skeletal
muscle effects, situational anxiety, and subjective experi-
ence of anxious affect. The stress subscale measured relax-
ation difficulty, nervous arousal, agitation, irritability and
impatience. Participants were requested to use a 4-point
severity/frequency scale to rate the extent to which they
had experienced each negative state over the past week.
Reliability for the three scales is 0.71 for depression, 0.79
for anxiety and 0.81 for stress [28]. The DASS anxiety sub-
scale has a correlation coefficient of 0.81 with the Beck
Anxiety Inventory whereas the DASS depression subscale
had 0.74 with the Beck Depression Inventory [31,32].
The MMAS is an 8-item scale used to measure medi-
cation adherence behavior in hypertensive patients and
responses are categorized as low adherence (<6),
medium adherence (6 - < 8), and high adherence (8).
Low and moderate scores were grouped as poor adher-
ence levels [33].
The ten-item SPS measured the belief perceptions of
participants relating to spiritually-related interactions.
Scores above or below the mean respectively repre-
sented high and low spiritual involvement. The SPS has
consistently been reliable with Cronbach’s alpha above
0.90 [34].






< 20 1 0.25
20 - 29 12 3.00
30 - 39 20 5.00
40 - 49 71 17.75
50 - 59 130
60 - 69 105 26.25













Christian (spiritual) 18 4.50
Christian (Charismatic/Pentecostal) 166 41.50
Christian (Orthodox) 174 43.50
Muslim 20 5.00
African Traditional Religion 4 1.00
Other 18 4.50
Number of years of having hypertension
≤ 10 years 318 79.50
11 – 20 years 49 12.25
21 – 30 years 20 5.00
31 – 40 years 12 3.00
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The data gathered from the study were analyzed with
the Statistical Package for Social Sciences (SPSS) version
20. Descriptive statistics were used to represent the
characteristics of participants. Anxiety, depression and
stress, and medication adherence as well as the level of
spirituality were evaluated using chi-square tests and lo-
gistic regression models.
Ethics
Ethical clearance from the institutional ethics committees
for KBTH and KATH were obtained before conducting
the study. The ethical approval codes are NMIMR-IRB
CPN 044/10-11and CHRPE/AP/022/12 respectively.
Results and discussions
Sample characteristics
A summary of the sample characteristics (mean and
standard deviation) of the hypertensive patients are pre-
sented in Table 1. Approximately 63% were women, 33%
were 50 to 59 years old, 64% were married, 90% were
Christians and 54% had a minimum of a secondary
school education. Of these approximately 80% had had
hypertension for ≥ 10 years, 42% had co-morbidities and
diabetes accounted for 60% of these. Anxiety, depression
and stress were not reported in the co-morbid health
conditions. This is to be expected as negative emotions
are usually not included in the co-morbidities reported
by patients [35]; and may partly be due to the lack of ad-
equate medical information being given to the patients.
This finding is however interpreted bearing in mind the
limitation that those co-morbidities were self-reported
and not obtained from the clinicians or from the patients’
health records.
Anxiety and adherence
Anxiety was common among 225 (57%) of the hyperten-
sive patients. This result corroborates the high prevalence
of anxiety found among hypertensive patients in varied
countries such as South Africa, China and Argentina
[10,36,37]; thus showing the presence of anxiety in hyper-
tension in spite of cultural variability. Anxiety in hyperten-
sion could result in a higher risk of morbidity and
mortality as a result of hastened cardiovascular events
[38]. Although it was not measured in the scope of the
present study, the anxiety may, in part, be specifically re-
lated to the medications or to the chronic health condition
[39]. Approximately 93% of participants poorly adhered to
their anti-hypertensive medications (Table 1). Although
previous studies had correlated anxiety and medication
adherence [12,14-16] the present study did not observe
any significant association between anxiety and adherence
(x2 = 3.887, p = 0.421), [(OR) = 1.6 (0.7 – 3.66), p = 0.262];yet our findings on the prevalence of anxiety calls for
clinicians to take critical action in addressing the nega-
tive emotional needs of anxious hypertensive patients
(Tables 2, 3 and 4).
Table 2 Distribution of degree of symptoms of depression, anxiety and stress
Emotional
condition
Normal Mild Moderate Severe Extremely severe
N (%) N (%) N (%) N (%) N (%)
Depression 358 (89.50) 25 (6.25) 12 (3.00) 4 (1.00) 1 (0.25)
Anxiety 129 (32.25) 46 (11.50) 140 (35.00) 44 (11.50) 41 (10.25)
Stress 259 (64.75) 59 (14.75) 52 (13.00) 26 (6.50) 4 (1.00)
A high number of patients experienced moderate to extremely severe symptoms of anxiety (225), followed by stress (82) and depression (17).
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Moderate to extremely severe levels of depressive symp-
toms which merit clinical attention were found in 17
(4%) study participants (Table 2). This information is
vital because of the increasing impact of depression on
the global disease burden [17]. Yet, depression among
hypertensive patients is usually not diagnosed [35]. As a
consequence such patients may be denied comprehen-
sive clinical care which takes their mental health into
consideration. Contrary to other studies which observed
participants with depression exhibiting a higher likeli-
hood of medication non-adherence [16,20,40], this asso-
ciation was not observed in the current study (x2 =
0.004, p = 0.950) which draws the same conclusion as
studies by Schweitzer et al. [14] and Corvera-Tindel
et al. [22]. These studies showed no relationship between
the two variables among patients with chronic heart fail-
ure. The outcome of a relationship between depression
and non-adherence is likely to be inconclusive due to
the small number of participants in this study exhibiting
symptoms of depression. However, it is essential for cli-
nicians to pay attention to these negative emotional
symptoms because overlooking them may further de-
crease attempts to manage the global burden of chronic
diseases.
Stress and adherence
Studies on emotional determinants of medication adher-
ence have focused primarily on anxiety and depressive
symptoms; however significant stressful events have been
reported to be responsible for hypertension [41,42]. We
reported 82 patients (20%) exhibiting moderate to severe
high scores of stress symptoms which may require clinical
attention and management (Table 2). Similar to earlier
studies on HIV/AIDS [24] and acute coronary syndrome
[25], stress was associated with medication non-adherenceTable 3 Relationship between negative emotional





At p < 0.05, stress and not depression and anxiety significantly related with
medication non-adherence.among the study participants (x2 = 5.936, p = 0.037). The
patients who were stressed were more likely to be non-
adherent than those who had no or low stress levels
[(OR) = 2.42 (1.06 – 5.5), p = 0.035]. A probable explan-
ation is that patients showing stress symptoms may be
more susceptible to the negative effects of their medica-
tions and thus may discontinue taking them. This obser-
vation further supports the need for health providers in
this area to pay particular attention to medication ad-
herence in patients who are stressed or those who could
potentially be affected by stress.Relationship between spirituality and anxiety, depression
and stress
Spirituality showed a significant association with lower
levels of anxiety (x2 = 13.352, p = 0.010), depression (x2 =
6.205, p = 0.045) and stress (x2 = 14.833, p = 0.001) (Table 5).
These strong spiritual attributes may have enabled patients
cope better with the emotional problems of having a
chronic condition like hypertension. Greater spiritual
well-being has been found to be associated with fewer
symptoms of anxiety, depression and stress [43-46]. Most
of these studies related to terminally ill patients yet, the
outcome from our study has demonstrated a confirmation
of the alleviating role of spirituality in emotional experi-
ences that can be applicable to hypertensive patients and
by extension, patients with other chronic conditions.
Some limitations are acknowledged. First, this study
was conducted in tertiary hospitals only, thus the views
of patients with hypertension in Ghana who seek medical
care from other healthcare facilities were not obtained.
Second, the use of a subjective measure of medication ad-
herence may give wrong adherence estimations. Future
studies could supplement patients’ report on adherence
with objective assessments of adherence.Table 4 A logistic regression model for negative
emotional symptoms and medication non-adherence
Variable OR 95% CI p value
Anxiety symptoms (present: ref absent) 1.6 0.7 – 3.66 0.262
Depressive symptoms (present: ref absent) 0.81 0.1 – 6.29 0.837
Stress symptoms (present: ref absent) 2.42 1.06 – 5.5 0.035
Adjusted for demographic and clinical characteristics.
Table 5 Relating spirituality with depression, anxiety and
stress symptoms experienced by hypertensive patients
Variable Depression Anxiety Stress
X2 p value X2 p value X2 p value
Spirituality 6.205 0.045 13.352 0.010 14.833 0.001
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Patients with hypertension manifested symptoms of anx-
iety, depression and stress. This implies that the patient’s
hypertensive state and perhaps the need for adherence
to the anti-hypertensive medications placed psychological
demands on their health. Thus, although hypertension
could be viewed in itself as a biomedical problem, patients’
experiences with the demands of living as hypertensives
resulted in mental health problems. This illustrates the
link between biomedical problems and the development
of psychological disorders. Further, spirituality helped
patients cope with the emotional burden of having hyper-
tension; a chronic disease. Therefore, the need to adopt
a multi-faceted perspective towards health delivery in
Ghana becomes real in the purview of these findings. The
involvement of clinicians, pharmacists, clinical/health psy-
chologists, religious leaders, and nurses thus becomes im-
portant in alleviating the problem of non-adherence and
invariably improving the quality of life outcomes of hyper-
tensive patients. Attention could be directed toward the
use of spirituality as a possible mechanism by which nega-
tive emotions are managed among hypertensive patients.Competing interests
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